52 related articles for article (PubMed ID: 1676580)
1. R-verapamil decreases anti-estrogen resistance in a breast cancer model.
Kellen JA; Wong A; Georges E; Ling V
Anticancer Res; 1991; 11(2):809-11. PubMed ID: 1676580
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical determination of P-glycoprotein in a rat mammary tumour treated with tamoxifen.
Kellen JA; Wong AC; Mirakian A
In Vivo; 1992; 6(5):541-4. PubMed ID: 1360843
[TBL] [Abstract][Full Text] [Related]
3. Toremifene resistance in a rat mammary tumour model.
Kellen JA; Georges E; Ling V; Dubsky M
Anticancer Res; 1992; 12(5):1663-5. PubMed ID: 1359832
[TBL] [Abstract][Full Text] [Related]
4. Decreased P-glycoprotein in a tamoxifen-tolerant breast carcinoma model.
Kellen JA; George E; Ling V
Anticancer Res; 1991; 11(3):1243-4. PubMed ID: 1679618
[TBL] [Abstract][Full Text] [Related]
5. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
[TBL] [Abstract][Full Text] [Related]
6. Antimetastatic effect of amiloride in an animal tumour model.
Kellen JA; Mirakian A; Kolin A
Anticancer Res; 1988; 8(6):1373-6. PubMed ID: 3218971
[TBL] [Abstract][Full Text] [Related]
7. A spontaneous estrogen dependent, tamoxifen sensitive mouse mammary tumor: a new model system to study hormone-responsiveness in immune competent mice.
Simian M; Manzur T; Rodriguez V; de Kier Joffé EB; Klein S
Breast Cancer Res Treat; 2009 Jan; 113(1):1-8. PubMed ID: 18183485
[TBL] [Abstract][Full Text] [Related]
8. Pyruvate inhibits growth of mammary adenocarcinoma 13762 in rats.
Stanko RT; Mullick P; Clarke MR; Contis LC; Janosky JE; Ramasastry SS
Cancer Res; 1994 Feb; 54(4):1004-7. PubMed ID: 8313354
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen tolerance and steroid receptors in a tumor model.
Kellen JA; Sutherland DJ
In Vivo; 1988; 2(3-4):299-300. PubMed ID: 2979847
[TBL] [Abstract][Full Text] [Related]
10. In vivo reversal of doxorubicin resistance by a new tiapamil analog Ro11-2933.
Alaoui-Jamali MA; Schecter RL; Rustum YM; Centurioni MG; Lehnert S; Batist G
J Pharmacol Exp Ther; 1993 Mar; 264(3):1299-304. PubMed ID: 8450465
[TBL] [Abstract][Full Text] [Related]
11. Combined treatment with verapamil, a calcium channel blocker, and B428, a synthetic uPA inhibitor, impairs the metastatic ability of a murine mammary carcinoma.
Todaro LB; Ladeda V; Bal de Kier Joffé E; Farías EF
Oncol Rep; 2003; 10(3):725-32. PubMed ID: 12684650
[TBL] [Abstract][Full Text] [Related]
12. The multidrug-resistance modifiers verapamil, cyclosporine A and tamoxifen induce an intracellular acidification in colon carcinoma cell lines in vitro.
Hamilton G; Cosentini EP; Teleky B; Koperna T; Zacheri J; Riegler M; Feil W; Schiessel R; Wenzi E
Anticancer Res; 1993; 13(6A):2059-63. PubMed ID: 7905252
[TBL] [Abstract][Full Text] [Related]
13. The effect of toremifene on the expression of genes in a rat mammary adenocarcinoma.
Kellen JA; Mirakian A
In Vivo; 1996; 10(5):511-3. PubMed ID: 8899431
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
Ting AY; Kimler BF; Fabian CJ; Petroff BK
Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo.
Jiang XP; Wang F; Yang DC; Elliott RL; Head JF
Anticancer Res; 2002; 22(5):2685-92. PubMed ID: 12529982
[TBL] [Abstract][Full Text] [Related]
16. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
17. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
Yusa K; Tsuruo T
Cancer Res; 1989 Sep; 49(18):5002-6. PubMed ID: 2569930
[TBL] [Abstract][Full Text] [Related]
18. Predictions from a preclinical model: studies of aromatase inhibitors and antiestrogens.
Brodie A; Jelovac D; Long BJ
Clin Cancer Res; 2003 Jan; 9(1 Pt 2):455S-9S. PubMed ID: 12538500
[TBL] [Abstract][Full Text] [Related]
19. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
20. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
